Drawing upon the comprehensive discussion of these data, α-T3 can effectively prevent the abnormal phosphorylation of tau, which is compelling evidence for the significant therapeutic and preventive potential of α-T3 for treating AD. The gene discussed is MAPT; the disease is Alzheimer disease.